Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-07
2006-02-07
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252190, C514S252200, C544S295000
Reexamination Certificate
active
06995159
ABSTRACT:
Compounds of Formula (IC) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2receptors in animals are described herein.
REFERENCES:
patent: 3299067 (1967-01-01), Regnier et al.
patent: 3457263 (1969-07-01), Regnier et al.
patent: 3980781 (1976-09-01), Snell et al.
patent: 4051244 (1977-09-01), Mattioda et al.
patent: 4081542 (1978-03-01), Lumma, Jr. et al.
patent: 4166852 (1979-09-01), Loiseau et al.
patent: 4435401 (1984-03-01), Campbell et al.
patent: 5138058 (1992-08-01), Geisen et al.
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 5447931 (1995-09-01), Baroni et al.
patent: 5728704 (1998-03-01), Mylari et al.
patent: 5863924 (1999-01-01), Berger et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5932581 (1999-08-01), Beyer et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6156755 (2000-12-01), Geisen
patent: 6326368 (2001-12-01), Chorvat et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: 0826674 (1998-03-01), None
patent: 1512101 (1975-08-01), None
patent: WO9118887 (1991-12-01), None
patent: WO9407867 (1994-04-01), None
patent: WO9639400 (1996-12-01), None
patent: WO9735580 (1997-10-01), None
patent: WO 98/23597 (1998-06-01), None
patent: WO0028993 (2000-05-01), None
patent: WO0240456 (2002-05-01), None
Regnier et al, “Dépresseurs du système nerveux central Étude de nouveaux derives de la purine” Chimie Thérapeutique, No. 3 (May-Jun. 1972).
Gueremy, C., et a.J. Med. Chem. “2-Amino-6-chloro-4-(N-methylpiperazino)pyrimidines, Inhibitors of Spiroperidol Binding” 25 pp. 1459-1465 (1982).
Romuald, Z., et al.Acta Po. Pharm. “Synthesis of Cyclic Derivatives of Quanidine With” 46 424-428 (1989).
Campbell, Simon F., et al.J. Med. Chem., “2,4-Diamino 6, 7-dimethoxyquinazolines. 3. 2-(4-Heterocyclylpiperazin-1-yl) Derivatives as x1-Adrenoceptor Antagonists and Antihypertensive Agents” vol. 30, pp. 1794-1798 (1987).
Chiang Phoebe
Novomisle William A.
Welch, Jr. Willard M.
Benson Gregg C.
Musser Arlene K.
Pfizer Inc.
Tucker Zachary C.
Wilson James O.
LandOfFree
5-HT receptor ligands and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT receptor ligands and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT receptor ligands and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687025